Tuesday, December 29, 2020

Zydus Cadila receives DCGI nod for NAFLD drug in India

Zydus Cadila receives DCGI nod for NAFLD drug in India The Drug Controller General of India (DCGI) has approved the new drug application (NDA) for Saroglitazar Mg for the treatment of non-alcoholic fatty liver disease (NAFLD) in India, Zydus Cadila said in a regulatory filing.

from Moneycontrol Business News https://ift.tt/2MjQTfu
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Paras Defence shares soar 10% as Q2 net profit jumps 50% to Rs 14 crore

Paras Defence and Space Technologies shares surged following strong September quarter results, with net profit jumping 50% and revenue climb...